Literature DB >> 11966512

Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: a case-control study in Italy.

D Palli1, M Menegatti, G Masala, C Ricci, C Saieva, J Holton, L Gatta, M Miglioli, D Vaira.   

Abstract

AIM: To evaluate the association between infection with specific strains of Helicobacter pylori and peptic ulcer in patients referred for upper gastrointestinal endoscopy.
METHODS: One thousand, six hundred and twenty-six consecutive dyspeptic patients, referred to one Endoscopy Unit in Bologna, Italy, were enrolled. For each participant, a blood sample was obtained for the measurement of distinct immunoglobulin G antibodies against H. pylori lysate and cytotoxin associated gene A (cagA). A case-control study included the whole series: patients diagnosed with duodenal (n=275) or gastric (n=71) ulcer were identified and independently compared with controls with non-ulcer dyspepsia (n=1280).
RESULTS: H. pylori seroprevalence (at least one positive marker) was associated with increasing age, male sex and a diagnosis of peptic ulcer. This association was stronger with duodenal ulcer (multivariate odds ratio (OR), 5.2; 95% confidence interval (CI), 3.5-7.9) than with gastric ulcer (OR, 2.3; 95% CI, 1.2-4.4). Further analyses showed that H. pylori lysate+/cagA- subjects had a moderately increased risk of duodenal (OR, 3.2), but not gastric (OR, 1.1), ulcer. When cagA+ subjects were separately compared with seronegative patients, there was a six-fold increased risk for duodenal ulcer and a three-fold increased risk for gastric ulcer.
CONCLUSIONS: A strong positive association between infection with a cagA+ H. pylori strain and the presence of peptic disease was found. The seroprevalence of anti-cagA antibodies among patients with non-ulcer dyspepsia is so high (41%) to preclude its use as a pre-endoscopic screening test.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966512     DOI: 10.1046/j.1365-2036.2002.01253.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

1.  Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type.

Authors:  P Lehours; S Dupouy; B Bergey; A Ruskoné-Foumestraux; J C Delchier; R Rad; F Richy; J Tankovic; F Zerbib; F Mégraud; A Ménard
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

2.  Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases.

Authors:  Sahar Honarmand-Jahromy; Farideh Siavoshi; Reza Malekzadeh; Taher Nejad Sattari; Saeid Latifi-Navid
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

3.  The relationship between virulence factors of Helicobacter pylori and severity of gastritis in infected patients.

Authors:  Hasan Umit; Ahmet Tezel; Sebnem Bukavaz; Gulbin Unsal; Muserref Otkun; Ali Riza Soylu; Dilek Tucer; Metin Otkun; Selcuk Bilgi
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

4.  Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy.

Authors:  Veronica Ojetti; Giovanni Bruno; Maria Elena Ainora; Giovanni Gigante; Gianluca Rizzo; Davide Roccarina; Antonio Gasbarrini
Journal:  Gastroenterol Res Pract       Date:  2012-05-29       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.